Horizon Blue Cross and Blue Shield of New Jersey policies, page 5

Search Horizon Blue Cross and Blue Shield of New Jersey's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

834 public policies Substrate tracks for Horizon Blue Cross and Blue Shield of New Jersey, by title.

Horizon Blue Cross and Blue Shield of New Jersey policies
PolicyDetailsCodesSource
Dupilumab (Dupixent)Commercial—Original policy ↗
Duplex ScanningEffective Aug 16, 2016 · Commercial, Medicaid1Original policy ↗
Duplicate Claim Logic for Independent Laboratory ServicesEffective Feb 25, 2019 · Commercial—Original policy ↗
Durvalumab (Imfinzi)Commercial—Original policy ↗
Dynamic PosturographyCommercial, Medicaid—Original policy ↗
Dynamic Spinal Visualization and Vertebral Motion AnalysisEffective Jul 8, 2019 · Commercial—Original policy ↗
Dynamic Splinting DevicesCommercial, Medicaid—Original policy ↗
Eculizumab (Soliris) and Ravulizumab-cwvz (Ultomiris)Commercial—Original policy ↗
Edaravone (Radicava)Commercial—Original policy ↗
Electrical and Electromagnetic Stimulation for the Treatment of ArthritisCommercial, Medicaid1Original policy ↗
Electrical Bone Growth Stimulation of the Appendicular SkeletonCommercial, Medicaid2Original policy ↗
Electrical Stimulation of the Spine as an Adjunct to Spinal Fusion ProceduresCommercial, Medicaid3Original policy ↗
Electrocardiographic Body Surface MappingCommercial, Medicaid—Original policy ↗
Electromagnetic Navigation BronchoscopyCommercial, Medicaid—Original policy ↗
Electromyography and Nerve Conduction StudiesCommercial, Medicaid—Original policy ↗
Electronic Salivary Reflex StimulatorCommercial, Medicaid—Original policy ↗
Electrostimulation and Electromagnetic Therapy for Treating WoundsCommercial, Medicaid—Original policy ↗
Electrotherapies in Pain ManagementCommercial, Medicaid1Original policy ↗
Elotuzumab (Empliciti)Commercial—Original policy ↗
Emapalumab-lzsg (Gamifant)Commercial—Original policy ↗
End Diastolic Pneumatic Compression Boot as a Treatment of Peripheral Vascular Disease or LymphedemaCommercial, Medicaid1Original policy ↗
Endobronchial BrachytherapyCommercial, Medicaid—Original policy ↗
Endobronchial Ultrasound for Diagnosis and Staging of Lung CancerCommercial—Original policy ↗
Endoscopic Radiofrequency Ablation or Cryoablation for Barrett EsophagusCommercial, Medicaid2Original policy ↗
Endothelial KeratoplastyCommercial—Original policy ↗
Endovascular Procedures for Intracranial Arterial Disease (Atherosclerosis and Aneurysms)Commercial1Original policy ↗
Endovascular Therapies for Extracranial Vertebral Artery DiseaseCommercial2Original policy ↗
Enfortumab vedotin-ejfv (Padcev)Commercial—Original policy ↗
Enhanced External Counterpulsation (EECP)Commercial, Medicaid—Original policy ↗
Epidural Spinal EndoscopyEffective Jul 25, 2020 · Commercial—Original policy ↗
Epidural Steroid InjectionsCMM-200 · Commercial—Original policy ↗
Epidurography, Radiological Supervision and InterpretationCMM-404 · Commercial, Medicaid1Original policy ↗
Epithelial Cell Cytology in Breast Cancer Risk Assessment and High-Risk Patient Management (Ductal Lavage and Suction Collection Systems)Commercial, Medicaid—Original policy ↗
Eptinezumab-jjmr (Vyepti)Commercial—Original policy ↗
Eribulin Mesylate (Halaven)Commercial—Original policy ↗
Erwinaze (Asparaginase Erwinia Chrysanthemi), Oncaspar (pegaspargase) and Asparlas (calaspargase pegol-mknl)Commercial—Original policy ↗
Erythropoietin Therapy: Epoetin Alfa, Darbepoetin Alfa, Pegylated (PEG)-epoetin Beta, and Epoetin Alfa-epbxCommercial—Original policy ↗
Esketamine (Spravato)Commercial—Original policy ↗
Esophageal pH MonitoringCommercial, Medicaid—Original policy ↗
Etelcalcetide (Parsabiv)—Original policy ↗
Eteplirsen (Exondys 51), Golodirsen (Vyondys 53), Viltolarsen (Viltepso) for Duchenne Muscular DystrophyCommercial—Original policy ↗
Evaluation and Management Services billed with Global Radiology, Stress Test, Stress Echo, Myocardial Profusion ImagingEffective Feb 25, 2019 · Commercial24Original policy ↗
Evaluation and Management Services in the Emergency DepartmentEffective Feb 1, 2025 · Commercial, Medicaid5Original policy ↗
Evaluation and Management Services with Chiropractic Manipulative TreatmentEffective Jul 27, 2015 · Commercial, Medicaid5Original policy ↗
Evaluation and Management Services with Osteopathic Manipulative TreatmentEffective Jul 27, 2015 · Commercial, Medicaid4Original policy ↗
Expanded Molecular Panel Testing of Cancers to Identify Targeted TherapiesCommercial—Original policy ↗
Explantation of Breast ImplantsCommercial, Medicaid—Original policy ↗
Extracorporeal Membrane Oxygenation for Adult ConditionsCommercial, Medicaid—Original policy ↗
Extracorporeal PhotopheresisCommercial, Medicaid—Original policy ↗
Extracorporeal Shock Wave Treatment for Plantar Fasciitis and Other Musculoskeletal ConditionsCommercial, Medicaid—Original policy ↗

Back to Horizon Blue Cross and Blue Shield of New Jersey

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.